Your browser doesn't support javascript.
loading
Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study.
Reveille, John D; Deodhar, Atul; Caldron, Paul H; Dudek, Anna; Harrison, Diane D; Kim, Lilianne; Lo, Kim Hung; Leu, Jocelyn H; Hsia, Elizabeth C.
Afiliación
  • Reveille JD; From the University of Texas McGovern Medical School, Houston, Texas; Oregon Health & Science University, Portland, Oregon; Arizona Arthritis and Rheumatology Associates, Phoenix, Arizona; Janssen Research & Development LLC, Spring House, Pennsylvania; University of Pennsylvania, Philadelphi
  • Deodhar A; J.D. Reveille, MD, University of Texas McGovern Medical School; A. Deodhar, MD, Oregon Health & Science University; P.H. Caldron, DO, Arizona Arthritis and Rheumatology Associates; A. Dudek, MD, PhD, AMED Medical Center; D.D. Harrison, MD, MPH, Janssen Research & Development LLC; L. Kim, PhD
  • Caldron PH; From the University of Texas McGovern Medical School, Houston, Texas; Oregon Health & Science University, Portland, Oregon; Arizona Arthritis and Rheumatology Associates, Phoenix, Arizona; Janssen Research & Development LLC, Spring House, Pennsylvania; University of Pennsylvania, Philadelphi
  • Dudek A; J.D. Reveille, MD, University of Texas McGovern Medical School; A. Deodhar, MD, Oregon Health & Science University; P.H. Caldron, DO, Arizona Arthritis and Rheumatology Associates; A. Dudek, MD, PhD, AMED Medical Center; D.D. Harrison, MD, MPH, Janssen Research & Development LLC; L. Kim, PhD
  • Harrison DD; From the University of Texas McGovern Medical School, Houston, Texas; Oregon Health & Science University, Portland, Oregon; Arizona Arthritis and Rheumatology Associates, Phoenix, Arizona; Janssen Research & Development LLC, Spring House, Pennsylvania; University of Pennsylvania, Philadelphi
  • Kim L; J.D. Reveille, MD, University of Texas McGovern Medical School; A. Deodhar, MD, Oregon Health & Science University; P.H. Caldron, DO, Arizona Arthritis and Rheumatology Associates; A. Dudek, MD, PhD, AMED Medical Center; D.D. Harrison, MD, MPH, Janssen Research & Development LLC; L. Kim, PhD
  • Lo KH; From the University of Texas McGovern Medical School, Houston, Texas; Oregon Health & Science University, Portland, Oregon; Arizona Arthritis and Rheumatology Associates, Phoenix, Arizona; Janssen Research & Development LLC, Spring House, Pennsylvania; University of Pennsylvania, Philadelphi
  • Leu JH; J.D. Reveille, MD, University of Texas McGovern Medical School; A. Deodhar, MD, Oregon Health & Science University; P.H. Caldron, DO, Arizona Arthritis and Rheumatology Associates; A. Dudek, MD, PhD, AMED Medical Center; D.D. Harrison, MD, MPH, Janssen Research & Development LLC; L. Kim, PhD
  • Hsia EC; From the University of Texas McGovern Medical School, Houston, Texas; Oregon Health & Science University, Portland, Oregon; Arizona Arthritis and Rheumatology Associates, Phoenix, Arizona; Janssen Research & Development LLC, Spring House, Pennsylvania; University of Pennsylvania, Philadelphi
J Rheumatol ; 46(10): 1277-1283, 2019 10.
Article en En | MEDLINE | ID: mdl-30824635
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Espondilitis Anquilosante / Antirreumáticos / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Rheumatol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Espondilitis Anquilosante / Antirreumáticos / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Rheumatol Año: 2019 Tipo del documento: Article